Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapies using caspase-1 dependent anticancer agents and PGE2 antagonists

Combination therapies using caspase-1 dependent anticancer agents and PGE2 antagonists

US Patent 11559537 · Granted Jan 24, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination therapies using immuno-DASH inhibitors and PGE2 antagonists2025
Combination therapies using immuno-DASH inhibitors and PGE2 antagonists2025
Integrated circuits with gate cut features2025
Semiconductor structure with staggered selective growth2025
FAP-activated proteasome inhibitors for treating solid tumors2025
FAP-activated proteasome inhibitors for treating solid tumors2025
Fap-activated therapeutic agents, and uses related thereto2024
Fap-activated therapeutic agents, and uses related thereto2024
Fap-activated therapeutic agents, and uses related thereto2024
FAP-activated therapeutic agents, and uses related thereto2024
FAP-activated therapeutic agents, and uses related thereto2024
FAP-activated therapeutic agents, and uses related thereto2024